A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment

N Engl J Med. 2020 Feb 20;382(8):692-694. doi: 10.1056/NEJMp2000929. Epub 2020 Jan 24.

Authors

Vincent J Munster¹, Marion Koopmans¹, Neeltje van Doremalen¹, Debby van Riel¹, Emmie de Wit¹

Affiliation

¹ From the Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT (V.J.M., N.D., E.W.); and the Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands (M.K., D.R.).

PMID: 31978293
DOI: 10.1056/NEJMp2000929

No abstract available

MeSH terms

Betacoronavirus / pathogenicity*
COVID-19
China / epidemiology
Communicable Disease Control
Coronavirus Infections / epidemiology
Coronavirus Infections / mortality
Coronavirus Infections / transmission*
Coronavirus Infections / virology
Disease Notification
Disease Outbreaks*
Humans
Mortality
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / mortality
Pneumonia, Viral / transmission
Pneumonia, Viral / virology
Population Surveillance
SARS-CoV-2